METTL3 and pancreatic neoplasm: In pancreatic cancer with proteasome inhibition by celastrol, METTL3 expression is decreased, m6A levels of Claspin and Bcl‐2 mRNA are lowered, and their expressions are suppressed by YTHDF3 binding, resulting in suppression of cell growth [51].